Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Journal of Perinatal Medicine

Official Journal of the World Association of Perinatal Medicine

Editor-in-Chief: Dudenhausen, MD, FRCOG, Joachim W.

Ed. by Bancalari, Eduardo / Chappelle, Joseph / Chervenak, Frank A. / D'Addario , Vincenzo / Genc, Mehmet R. / Greenough, Anne / Grunebaum, Amos / Konje, Justin C. / Kurjak M.D., Asim / Romero, Roberto / Zalud, MD PhD, Ivica


IMPACT FACTOR 2017: 1.558
5-year IMPACT FACTOR: 1.653

CiteScore 2017: 1.26

SCImago Journal Rank (SJR) 2017: 0.594
Source Normalized Impact per Paper (SNIP) 2017: 0.684

Online
ISSN
1619-3997
See all formats and pricing
More options …
Volume 41, Issue 4

Issues

Maternal and fetal adropin levels in gestational diabetes mellitus

Ebru Celik
  • Corresponding author
  • Department of Obstetrics and Gynecology, TurgutOzal Medical Center, Inonu University School of Medicine, 44315, Malatya, Turkey
  • Email
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Ercan Yilmaz / Onder Celik / Mustafa Ulas / Ilgin Turkcuoglu / Abdullah Karaer / Yavuz Simsek / Yagmur Minareci / Suleyman Aydin
Published Online: 2013-01-09 | DOI: https://doi.org/10.1515/jpm-2012-0227

Abstract

Aim: To evaluate maternal and cord blood serum adropin concentrations in pregnant women with gestational diabetes mellitus (GDM).

Study design: Twenty pregnant women with GDM and 20 gestational age-matched healthy pregnant women participated in the study. Maternal serum and cord blood adropin levels were assessed using an enzyme immunosorbent assay, at the time of birth. The relation of maternal serum and cord blood adropin levels with metabolic parameters were also assessed.

Results: The mean maternal and cord serum adropin in the GDM group were significantly lower than those of the control women (P=0.01 and P<0.001, respectively). Maternal serum adropin levels did not correlate with either fetal serum adropin levels or maternal metabolic values.

Conclusion: The data suggest that low adropin levels may contribute to the underlying pathogenesis of GDM.

Keywords: Adropin; cord blood; gestational diabetes mellitus; glucose; homeostasis model of assessment – insulin resistance (HOMA-IR)

References

  • [1]

    American Diabetes Association: Diagnosis and classification of diabetes mellitus. Diabetes Care. 2006;29(Suppl 1):43–8.Web of ScienceGoogle Scholar

  • [2]

    Butler AA, Tam CS, Stanhope KL, Wolfe BM, Ali MR, O’Keeffe M, et al. Low circulating adropin concentrations with obesity and aging correlate with risk factors for metabolic disease and increase after gastric bypass surgery in humans. J Clin Endocrinol Metab. 2012;97:3783–91.Google Scholar

  • [3]

    Farías M, San Martín R, Puebla C, Pearson JD, Casado JF, Pastor-Anglada M, et al. Nitric oxide reduces adenosine transporter ENT1 gene (SLC29A1) promoter activity in human fetal endothelium from gestational diabetes. J Cell Physiol. 2006;208:451–60.Google Scholar

  • [4]

    Ganesh Kumar K, Zhang J, Gao S, Rossi J, McGuinness OP, Halem HH, et al. Adropin deficiency is associated with increased adiposity and insulin resistance. Obesity (Silver Spring). 2012;20:1394–402.CrossrefGoogle Scholar

  • [5]

    Guzmán-Gutiérrez E, Abarzúa F, Belmar C, Nien JK, Ramírez MA, Arroyo P, et al. Functional link between adenosine and insulin: a hypothesis for fetoplacental vascular endothelial dysfunction in gestational diabetes. Curr Vasc Pharmacol. 2011;9:750–62.CrossrefWeb of ScienceGoogle Scholar

  • [6]

    International Association of Diabetes and Pregnancy Study Groups Consensus Panel, Metzger BE, Gabbe SG, Persson B, Buchanan TA, Catalano PA, Damm P, et al. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care. 2010;33:676–82.Web of ScienceGoogle Scholar

  • [7]

    Kaaja RJ, Greer IA. Manifestations of chronic disease during pregnancy. J Am Med Assoc. 2005;294:2751–7.Google Scholar

  • [8]

    King H. Epidemiology of glucose intolerance and gestational diabetes in women of childbearing age. Diabetes Care. 1998;21:B9–B13.PubMedGoogle Scholar

  • [9]

    Kumar KG, Trevaskis JL, Lam DD, Sutton GM, Koza RA, Chouljenko VN, et al. Identification of adropin as a secreted factor linking dietary macronutrient intake with energy homeostasis and lipid metabolism. Cell Metab. 2008;8:468–81.PubMedCrossrefWeb of ScienceGoogle Scholar

  • [10]

    Leach L. Placental vascular dysfunction in diabetic pregnancies: intimations of fetal cardiovascular disease? Microcirculation. 2011;18:263–9.PubMedCrossrefWeb of ScienceGoogle Scholar

  • [11]

    Lian W, Gu X, Qin Y, Zheng X. Elevated plasma levels of adropin in heart failure patients. Intern Med. 2011;50:1523–7.Web of ScienceGoogle Scholar

  • [12]

    Lovren F, Pan Y, Quan A, Singh KK, Shukla PC, Gupta M, et al. Adropin is a novel regulator of endothelial function. Circulation. 2010;122:185–92.Web of ScienceGoogle Scholar

  • [13]

    Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412–9.CrossrefPubMedGoogle Scholar

  • [14]

    Naylor CD, Sermer M, Chen E, Farine D. Selective screening for gestational diabetes mellitus. N Engl J Med. 1997;337:1591–6.Google Scholar

  • [15]

    Ozumba BC, Obi SN, Oli JM. Diabetes mellitus in pregnancy in an African population. Int J Gynaecol Obstet. 2004;84:114–9.Google Scholar

  • [16]

    Pandolfi A, Di Pietro N. High glucose, nitric oxide, and adenosine: a vicious circle in chronic hyperglycaemia? Cardiovasc Res. 2010;86:9–11.CrossrefWeb of SciencePubMedGoogle Scholar

  • [17]

    Seshiah V, Balaji V, Balaji MS, Sanjeevi CB, Green A. Gestational diabetes mellitus in India. J Assoc Physicians India. 2004;52:707–11.Google Scholar

  • [18]

    Sobrevia L, Abarzúa F, Nien JK, Salomón C, Westermeier F, Puebla C, et al. Differential placental macrovascular and microvascular endothelial dysfunction in gestational diabetes. Placenta. 2011;32:159–64.CrossrefWeb of ScienceGoogle Scholar

  • [19]

    Solomon CG, Willett WC, Carey VJ, Rich-Edwards J, Hunter DJ, Colditz GA, et al. A prospective study of pregravid determinants of gestational diabetes mellitus. J Am Med Assoc. 1997;278:1078–83.Google Scholar

  • [20]

    Torloni MR, Betrán AP, Horta BL, Nakamura MU, Atallah AN, Moron AF, et al. Prepregnancy BMI and the risk of gestational diabetes: a systematic review of the literature with meta-analysis. Obes Rev. 2009;10:194–203.Web of ScienceCrossrefGoogle Scholar

  • [21]

    Westermeier F, Salomón C, González M, Puebla C, Guzmán-Gutiérrez E, Cifuentes F, et al. Insulin restores gestational diabetes mellitus-reduced adenosine transport involving differential expression of insulin receptor isoforms in human umbilical vein endothelium. Diabetes. 2011; 60:1677–87.Web of ScienceGoogle Scholar

  • [22]

    Wolfe HM, Zador IE, Gross TL, Martier SS, Sokol RJ. The clinical utility of maternal body mass index in pregnancy. Am J Obstet Gynecol. 1991;164:1306–10.Google Scholar

About the article

Corresponding author: Ebru Celik, MD, Department of Obstetrics and Gynecology, TurgutOzal Medical Center, Inonu University School of Medicine, 44315, Malatya, Turkey, Tel.: +90 532 603 5151, Fax: +90 422 3410660


Received: 2012-09-19

Accepted: 2012-12-03

Published Online: 2013-01-09

Published in Print: 2013-07-01


Citation Information: Journal of Perinatal Medicine, Volume 41, Issue 4, Pages 375–380, ISSN (Online) 1619-3997, ISSN (Print) 0300-5577, DOI: https://doi.org/10.1515/jpm-2012-0227.

Export Citation

©2013 by Walter de Gruyter Berlin Boston.Get Permission

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Huanhuan Zang, Fusong Jiang, Xingbo Cheng, Hong Xu, and Xingna Hu
Endocrine Journal, 2018, Volume 65, Number 7, Page 685
[2]
Gulsah Gundogdu and Koksal Gundogdu
Clinical Rheumatology, 2018
[3]
Spencer P. Loewen and Alastair V. Ferguson
American Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2017, Volume 312, Number 4, Page R511
[4]
Lauren M. Stein, Gina L. C. Yosten, and Willis K. Samson
American Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2016, Volume 310, Number 6, Page R476
[5]
Artemis Bousmpoula, Evangelia Kouskouni, Evangelos Benidis, Styliani Demeridou, Rachil Kapeta-Kourkouli, Anthia Chasiakou, and Stavroula Baka
Gynecological Endocrinology, 2017, Page 1
[6]
Bilge G. Tuna, Pinar B. Atalay, Mine Altunbek, Batuhan M. Kalkan, and Soner Dogan
Nutrition and Cancer, 2017, Page 1
[7]
Chi-Ming Wong, Yudong Wang, Jimmy Tsz Hang Lee, Zhe Huang, Donghai Wu, Aimin Xu, and Karen Siu Ling Lam
Journal of Biological Chemistry, 2014, Volume 289, Number 37, Page 25976
[8]
Rizaldy C. Zapata, Melissa D. Meachem, Natalia Cavalca Cardoso, Susan O. Mehain, Chantal J. McMillan, Elisabeth R. Snead, and Prasanth K. Chelikani
BMC Veterinary Research, 2017, Volume 13, Number 1
[9]
Huihua Wang, Bo Gao, Zaigui Wu, Hanzhi Wang, and Minyue Dong
Pregnancy Hypertension: An International Journal of Women's Cardiovascular Health, 2017, Volume 8, Page 6
[10]
Wenchao Hu and Li Chen
Mediators of Inflammation, 2016, Volume 2016, Page 1
[11]
Joseph R. Stevens, Monica L. Kearney, Marie-Pierre St-Onge, Kimber L. Stanhope, Peter J. Havel, Jill A. Kanaley, John P. Thyfault, Edward P. Weiss, and Andrew A. Butler
Obesity, 2016, Volume 24, Number 8, Page 1731
[13]
T. Kume, M. Calan, O. Yilmaz, G. U. Kocabas, P. Yesil, M. Temur, M. Bicer, and O. G. Calan
Journal of Endocrinological Investigation, 2016, Volume 39, Number 7, Page 747
[14]
Sheng-ping Wang, Yun-ling Gao, Gang Liu, Dun Deng, Rong-jun Chen, Yu-zhe Zhang, Li-li Li, Qing-qi Wen, Yong-qing Hou, Ze-meng Feng, and Zhao-hui Guo
Journal of Zhejiang University-SCIENCE B, 2015, Volume 16, Number 6, Page 524
[15]
Liang Li, Wei Xie, Xi-Long Zheng, Wei-Dong Yin, and Chao-Ke Tang
Clinica Chimica Acta, 2016, Volume 453, Page 107
[16]
Stavroula Baka, Ariadne Malamitsi-Puchner, Despina D. Briana, Maria Boutsikou, Antonios Marmarinos, Dimitrios Gourgiotis, and Theodora Boutsikou
The Journal of Maternal-Fetal & Neonatal Medicine, 2015, Page 1
[17]
Aboutaleb Beigi, Nooshin Shirzad, Fatemeh Nikpour, Ensieh Nasli Esfahani, Solaleh Emamgholipour, and Fatemeh Bandarian
Gynecological Endocrinology, 2015, Volume 31, Number 12, Page 939
[18]
Sümeyra Nergiz, Sunduz Ozlem Altinkaya, İmran Kurt Ömürlü, Hasan Yuksel, Mert Küçük, and Selda Demircan Sezer
Gynecological Endocrinology, 2015, Volume 31, Number 9, Page 730
[19]
Su Gao, Ryan P. McMillan, Qingzhang Zhu, Gary D. Lopaschuk, Matthew W. Hulver, and Andrew A. Butler
Molecular Metabolism, 2015, Volume 4, Number 4, Page 310
[21]
Xiu Qiu, Jian-Rong He, Ming-Guang Zhao, Ya-Shu Kuang, Shu-Qin Xu, Hui-Zhu Zhang, Shun-Ping Hu, Jun Chen, and Hui-Min Xia
Peptides, 2014, Volume 52, Page 19
[22]
Marie-Pierre St-Onge, Ari Shechter, Julie Shlisky, Charmaine S. Tam, Su Gao, Eric Ravussin, and Andrew A. Butler
Obesity, 2014, Volume 22, Number 4, Page 1056

Comments (0)

Please log in or register to comment.
Log in